.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 8,759,401

« Back to Dashboard

Claims for Patent: 8,759,401

Title:Aqueous gel formulation and method for inducing topical anesthesia
Abstract: Disclosed is a stable aqueous gel formulation suitable for topical use comprising water, an anesthetic (e.g., lidocaine hydrochloride), a viscoelastic polymer, and a tonicity modifier, wherein the aqueous gel formulation is free of preservatives and phosphate buffer, is isotonic with physiological fluids, and is sterile and has low particulate count. Also disclosed is a method of inducing topical anesthesia on a tissue or organ, e.g., the eye, of an animal comprising providing a stable aqueous gel formulation comprising water, an anesthetic, a viscoelastic polymer, and a tonicity modifier, wherein the aqueous gel formulation is free of preservatives and phosphate buffer, is isotonic with physiological fluids, and is sterile, and topically administering an effective amount of the aqueous gel formulation to the tissue or organ of the animal.
Inventor(s): Alam; Abu (Lake Forest, IL), Reichel; Elias (Weston, MA), Busbee; Brandon (Nashville, TN)
Assignee: Akorn, Inc. (Lake Forest, IL)
Application Number:13/961,453
Patent Claims: 1. An aqueous gel formulation consisting of water, lidocaine hydrochloride, a viscoelastic polymer, and sodium chloride, wherein the lidocaine hydrochloride is present in an amount of 35 mg per ml of the formulation and the sodium chloride is present in an amount of 9 mg per ml of the formulation, wherein the aqueous gel formulation has a viscosity of 2000 to 10,000 cps at 25.degree. C., is free of preservatives and phosphate buffer, has an osmolality of 250 to 350 mOsm/kg, and is sterile having less than about 100 particles of 50 microns particle size or greater per ml of the aqueous gel formulation, wherein the viscoelastic polymer is hydroxypropylmethylcellulose, the pH of the aqueous gel formulation is from 5.0 to 7.0, and the aqueous gel formulation is suitable for administration to the eye of an animal.

2. A method of inducing topical anesthesia in the eye of an animal comprising: (a) providing an aqueous gel formulation according to claim 1 and (b) topically administering an effective amount of the aqueous gel formulation to the eye of the animal; whereby anesthesia is induced on the eye of the animal.

3. The method of claim 2, wherein the anesthesia onsets within 5 minutes of administration of the aqueous gel formulation.

4. The method of claim 2, wherein the anesthesia lasts up to 30 minutes or more.

5. The aqueous gel formulation of claim 1, which is packaged in a unit dose container.

6. The aqueous gel formulation of claim 1, whose pH is from 5.5 to 7.0.

7. The aqueous gel formulation of claim 1, whose pH is from 5.5 to 6.5.

8. The aqueous gel formulation of claim 1, whose pH is from 6.0 to 6.5.

9. The aqueous gel formulation of claim 5, wherein the unit dose container is a dropper bottle.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc